Please login to the form below

Not currently logged in
Email:
Password:

PCSK9 inhibitors

This page shows the latest PCSK9 inhibitors news and features for those working in and with pharma, biotech and healthcare.

TMC rockets on data for twice-yearly cholesterol drug inclisiran

TMC rockets on data for twice-yearly cholesterol drug inclisiran

The small, interfering RNA (siRNA) drug – which works by blocking the synthesis of PCSK9 in the liver – was being tested in patients with atherosclerotic cardiovascular disease (ASCVD) who were unable to ... That is a much less frequent dosing

Latest news

More from news
Approximately 1 fully matching, plus 36 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Star

We're passionate about helping our clients to make a real commercial impact. We achieve this through our unique approach to...

Latest intelligence

Article: Like, Like, Like: Harnessing the power of social media insights
...
Its Know Your Numbers week
Do you know yours?...
What is changing in mental health and dementia care?
Paul Midgley, of Wilmington Healthcare, takes a look at the NHS Long Term Plan's bid to transform mental health and dementia services...

Infographics